HCA Healthcare (HCA) FY2023 results: revenue $65.0 billion, up 7.9% on the year
HCA Healthcare, Inc. (HCA) reported revenue of $65.0 billion for fiscal 2023, the year ended 31 December 2023, up 7.9% on the year before. Net income was $5.2 billion, down 7.1%, and diluted earnings per share $18.97. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2024.
Revenue
$65.0 billion
+7.9% on the year
FY2016FY2023
Operating margin
11.9%
14.2% a year earlier
FY2016FY2023
Net income
$5.2 billion
-7.1% on the year
FY2016FY2023
Diluted EPS
$18.97
-0.9% on the year
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
9,431
8,522
8,959
+10.7%
Capital expenditure
4,744
4,395
3,577
+7.9%
Free cash flow
4,687
4,127
5,382
+13.6%
Free cash flow margin
7.2%
6.9%
9.2%
Cash from investing
-5,317
-3,389
-2,643
Cash from financing
-4,094
-5,656
-6,655
Depreciation and amortisation
3,077
2,969
2,853
+3.6%
Share-based compensation
262
341
440
-23.2%
Buybacks
3,811
7,000
8,215
-45.6%
Dividends paid
661
653
624
+1.2%
Dividend per share
$2.40
$2.24
$1.92
+7.1%
Diluted shares, weighted
276m
295m
329m
-6.2%
Shares outstanding at period end
266m
277m
305m
-4.3%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
-1,774
-2,767
-933
Non-controlling interest
2,834
2,694
2,422
+5.2%
Debt
39,593
38,084
34,579
+4.0%
Operating lease liabilities
1,903
1,752
1,755
+8.6%
Finance lease liabilities
541
579
577
-6.6%
Other liabilities
13,114
12,096
12,342
+8.4%
Total liabilities and equity
56,211
52,438
50,742
+7.2%
Fixed assets
27,715
25,575
24,063
+8.4%
Investments
477
381
541
+25.2%
Cash and equivalents
935
908
1,451
+3.0%
Receivables
9,958
8,891
8,095
+12.0%
Inventory
2,021
2,068
1,986
-2.3%
Other assets
15,105
14,615
14,606
+3.4%
Total assets
56,211
52,438
50,742
+7.2%
10-K for the year ended 31 December 2023, filed 16 February 2024: the filing.